Dr. Aditi Bhatt

Dr. Bhatt is a highly accomplished Surgical Oncologist with over 15 years of experience in treating complex oncological cases. She specializes in Cytoreductive Surgery (CRS), Hyperthermic Intraperitoneal Chemotherapy (HIPEC), and Peritoneal Surface Oncology, with a strong focus on gastrointestinal and gynecological cancers. A Gold Medalist in MS (General Surgery) from B J Medical College, Ahmedabad, Dr. Bhatt further honed her expertise through prestigious fellowships in France and the USA. She has held key positions at leading hospitals, including Fortis, HCG, and Zydus, and currently serves as a Senior Consultant at Shalby Hospital SG, Ahmedabad.

• MCh in Surgical Oncology (2009) – Gujarat Cancer & Research Institute (GCRI), B J Medical College, Gujarat University, Ahmedabad
• MS in General Surgery (2005) – B J Medical College, Gujarat University, Ahmedabad
  Awarded Gold Medal for highest marks in MS (General Surgery)
• MBBS (2001) – B J Medical College, Gujarat University, Ahmedabad

• Senior Consultant, Surgical Oncology, Shalby Hospital SG, Ahmedabad (July 2024 to Present)
• Senior Consultant, Surgical Oncology, KD Hospital, Ahmedabad (Feb 2023 – June 2024)
• Consultant, Surgical Oncology, Zydus Hospital, Ahmedabad (2017-2023)
• Consultant, Surgical Oncology, Fortis Hospital, Bangalore (2014-2017)
• Consultant, Surgical Oncology, HCG Bangalore Institute of Oncology (2010-2013)
• Consultant, Surgical Oncology, Mazumdar Shaw Cancer Center, Bangalore (2009-2010)

• Top Reviewer Award, European Journal of Surgical Oncology (2023)
• Gold Medal, MS General Surgery for highest marks

• Institut Gustave Roussy, Paris, France (March-May 2010)
• Paul Brousse Hospital and Hepatobiliary Centre, Paris, France (June 2010)
• Memorial Sloan Kettering Cancer Center, Colorectal Service, USA (May 2012, Observership)
• Founding Member & Secretary, Society of Peritoneal Surface Oncology (India), 2017
• Executive Committee Member, Peritoneal Surface Oncology Group International (since 2021)
• Section Editor, Indian Journal of Surgical Oncology (since 2019)
• Editorial Board Member, British Journal of Surgery (since June 2023)
• Member, Indian Association of Surgical Oncology (IASO) since 2014

• Cytoreductive Surgery (CRS)
• Hyperthermic Intraperitoneal Chemotherapy (HIPEC)
• Peritoneal Surface Oncology
• Gastrointestinal Cancers
• Gynecological Oncology

Dr. Bhatt has published 85 scientific papers in prestigious journals, with her highest impact factor being 52 for a paper published in Nature Reviews. She has made significant contributions to the study of peritoneal metastases and the outcomes of CRS and HIPEC procedures.

She is the principal investigator for several clinical trials registered with the Clinical Trials Registry of India (CTRI), focusing on peritoneal dissemination, chemotherapy responses, and surgical techniques in ovarian and peritoneal cancers. Key research studies include:

1. Patterns of peritoneal dissemination in peritoneal tumors
2. Comparative studies of primary vs. interval CRS for advanced ovarian cancer
3. HIPEC outcomes in advanced ovarian cancer (TORPEDO Study)

Publications & Research

1. Management of Peritoneal Metastases – Cytoreductive Surgery, HIPEC, and Beyond (Springer, 2018)
2. Pathology of Peritoneal Metastases – The Uncharted Fields (Springer, 2020)

Dr. Bhatt has also served as a guest editor for special issues on peritoneal malignancies in the Indian Journal of Surgical Oncology (2016, 2019, and 2023).